Chevron Nigeria Limited, (CNL), an affiliate of Chevron Corporation (Chevron), announced the disbursement of US$2.5 million donated by Chevron to the Global Fund to Fight AIDS, Tuberculosis and Malaria, for the implementation of the Chevron-Global Fund Anti-Retroviral Treatment Service Maintenance Program (ART Program), in Delta, Bayelsa, Ondo and Lagos States, Vanguard reports.
In 2018, a final instalment of US$2.5 million will be disbursed to support these HIV programs, amounting to a total contribution of US$5 million by Chevron. These funds are in addition to US$6.7 million earlier donated by Chevron to the Prevention of Mother-To-Child Transmission of HIV (PMTCT) in Bayelsa State, Nigeria.
These disbursements are part of a nine-year, US$60 million commitment from Chevron to the Global Fund. The Global Fund raises and invests nearly US$4 billion a year to support programs run by local experts to fight the three diseases in countries and communities most in need. The Global Fund is one of the world’s largest international financiers of health care programs fighting these three diseases.